Newly Funded Medicine To Benefit 110 More People With Thyroid, Liver, And Kidney Cancer

Dr David Hughes, Pharmac’s Chief Medical Officer, says feedback on the public consultation helped Pharmac make small changes to the final eligibility criteria for kidney and thyroid cancer to make sure the right people can access treatment.